BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10998124)

  • 1. Dopamine control of striatal gene expression during development: relevance to knockout mice for the dopamine transporter.
    Fauchey V; Jaber M; Bloch B; Le Moine C
    Eur J Neurosci; 2000 Sep; 12(9):3415-25. PubMed ID: 10998124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
    Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
    Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons.
    Wong JY; Padungchaichot P; Massalas JS; Drago J
    Neuroscience; 2000; 95(4):1035-41. PubMed ID: 10682710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of striatal dopaminergic function. I. Pre- and postnatal development of mRNAs and binding sites for striatal D1 (D1a) and D2 (D2a) receptors.
    Jung AB; Bennett JP
    Brain Res Dev Brain Res; 1996 Jul; 94(2):109-20. PubMed ID: 8836569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical changes in dopamine D1, D3 and D1/D3 receptor knockout mice.
    Wong JY; Clifford JJ; Massalas JS; Finkelstein DI; Horne MK; Waddington JL; Drago J
    Eur J Pharmacol; 2003 Jul; 472(1-2):39-47. PubMed ID: 12860471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice.
    Gross CE; Ravenscroft P; Dovero S; Jaber M; Bioulac B; Bezard E
    J Neurochem; 2003 Mar; 84(6):1246-55. PubMed ID: 12614325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
    Haber SN; Ryoo H; Cox C; Lu W
    J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular distribution of adenosine A2A receptor mRNA in the primate striatum.
    Svenningsson P; Le Moine C; Aubert I; Burbaud P; Fredholm BB; Bloch B
    J Comp Neurol; 1998 Sep; 399(2):229-40. PubMed ID: 9721905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
    Aubert I; Ghorayeb I; Normand E; Bloch B
    J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of BDNF and trkB mRNAs in comparison to dopamine D1 and D2 receptor mRNAs and tyrosine hydroxylase-immunoreactivity in nigrostriatal in oculo co-grafts.
    Strömberg I; Humpel C
    Brain Res Dev Brain Res; 1995 Feb; 84(2):215-24. PubMed ID: 7743642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal ontogeny of D2 dopamine receptor and dopamine transporter gene expression in the rat mesencephalon.
    Tison F; Normand E; Bloch B
    Neurosci Lett; 1994 Jan; 166(1):48-50. PubMed ID: 7910679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.
    Jaber M; Dumartin B; Sagné C; Haycock JW; Roubert C; Giros B; Bloch B; Caron MG
    Eur J Neurosci; 1999 Oct; 11(10):3499-511. PubMed ID: 10564358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
    Young WS; Bonner TI; Brann MR
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9827-31. PubMed ID: 2432603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of in utero cocaine exposure on the expression of mRNAS encoding the dopamine transporter and the D1, D2 and D5 dopamine receptor subtypes in fetal rhesus monkey.
    Choi WS; Rønnekleiv OK
    Brain Res Dev Brain Res; 1996 Oct; 96(1-2):249-60. PubMed ID: 8922687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats.
    Wang JQ; McGinty JF
    Neuroscience; 1996 Nov; 75(1):43-56. PubMed ID: 8923522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early direct and transneuronal effects in mice with targeted expression of a toxin gene to D1 dopamine receptor neurons.
    Padungchaichot P; Wong JY; Natoli AL; Massalas JS; Finkelstein DI; Lawrence AL; Drago J
    Neuroscience; 2000; 95(4):1025-33. PubMed ID: 10682709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive gene expression changes on the healthy side of parkinsonian rats.
    Capper-Loup C; Frey CM; Rebell D; Kaelin-Lang A
    Neuroscience; 2013 Mar; 233():157-65. PubMed ID: 23270858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis.
    Gerfen CR; McGinty JF; Young WS
    J Neurosci; 1991 Apr; 11(4):1016-31. PubMed ID: 1707092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontogeny of the proenkephalin system in the rat corpus striatum: its relationship to dopaminergic innervation and transient compartmental expression.
    Song DD; Harlan RE
    Neuroscience; 1993 Feb; 52(4):883-909. PubMed ID: 8095712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum.
    Hervé D; Le Moine C; Corvol JC; Belluscio L; Ledent C; Fienberg AA; Jaber M; Studler JM; Girault JA
    J Neurosci; 2001 Jun; 21(12):4390-9. PubMed ID: 11404425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.